Advances in and prospects of immunotherapy for prostate cancer
Source : https://pubmed.ncbi.nlm.nih.gov/39127338/
Immunotherapy has shown promising therapeutic effects in hematological malignancies and certain solid tumors and has emerged as a critical and highly potential treatment modality for cancer. However, prostate cancer falls...
Immunotherapy for prostate cancer is limited due to its immunosuppressive microenvironment. Advances in immune modulation offer potential strategies to enhance treatment efficacy.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial
Source : https://pubmed.ncbi.nlm.nih.gov/38763154/
Cancer Research UK, UK Research and Innovation (formerly Medical Research Council), and Canadian Cancer Society.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy did not improve metastasis-free survival in patients with prostate cancer following radical prostatectomy.
Unveiling the Dual Threat: How Microbial Infections and Healthcare Deficiencies Fuel Cervical and Prostate Cancer Deaths in Africa
Source : https://pubmed.ncbi.nlm.nih.gov/38535586/
Cervical and prostate cancer account for 7.1 and 7.3 deaths per 100,000 people globally in 2022. These rates increased significantly to 17.6 and 17.3 in Africa, respectively, making them the...
High mortality rates of cervical and prostate cancer in Africa are driven by untreated microbial infections and poor healthcare systems, significantly surpassing global averages.
A review of tanshinone compounds in prostate cancer treatment
Source : https://pubmed.ncbi.nlm.nih.gov/39100845/
Prostate cancer (PCa) is one of the most common malignant epithelial tumors in men worldwide. PCa patients are initially sensitive to chemotherapy, but patients in the advanced stages of PCa...
TAN compounds, especially TAN IIA, show promising anticancer activity against prostate cancer, but further research is needed to confirm their safety, efficacy, and clinical application.
Different Roles of Tocopherols and Tocotrienols in Chemoprevention and Treatment of Prostate Cancer
Source : https://pubmed.ncbi.nlm.nih.gov/38734077/
The vitamin E family contains α-tocopherol (αT), βT, γT, and δT and α-tocotrienol (TE), βTE, γTE, and δTE. Research has revealed distinct roles of these vitamin E forms in prostate...
Modest α-tocopherol may benefit smokers, while γ-tocopherol, δ-tocopherol, γ-tocotrienol, and δ-tocotrienol show promise in preventing prostate cancer and warrant further clinical research.